Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06641791 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 9 to 10
  2. Primary endpoints: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints: details revised at 3 of 7 entries
    • Site details revised at 2 of 9 sites
  3. Study sites: 8 to 9v14
  4. Study sites: 7 to 8v13
  5. Study sites: 6 to 7v12
Show 10 earlier versionsHide 10 earlier versions
  1. Study sites: 5 to 6v11
  2. Re-verified, no change to tracked fieldsv10
  3. Site details revised at 1 of 5 sitesv9
  4. Study sites: 4 to 5v8
  5. Eligibility criteria expanded, about 40 wordsv7
  6. Study sites: 2 to 4v6
  7. Study sites: 1 to 2v5
  8. Start date: Apr 1, 2025 to Apr 7, 2025v4
  9. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 28, 2025 to Apr 1, 2025
    v3
  10. Start date: Jan 1, 2025 to Feb 28, 2025v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being done to answer the following question: Does stereotactic body radiation therapy (SBRT) provide better cancer control compared to standard radiation therapy (RT) for those with advanced head and neck cancer?
Trial Details
NCT Number NCT06641791
Lead Sponsor Canadian Cancer Trials Group
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions
(from sponsor)		 Advanced Head and Neck Cancer
Related terms Head and Neck Neoplasms
Enrollment 196 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov